Take a look back at our most popular news from January 2022.
Did you miss the top stories on Drug Topics® this month? Catch up on these noteworthy stories today.
10. Prescribing Transparency as the Solution to Pharmacy Owner Woes
Without transparency, pharmacy owners must clear numerous hurdles to run an effective business.
9. Oral Shingles Are A Mouthful of Pain
Prompt treatment can reduce pain and complications.
8. How to Help Make Health Equity a Reality
CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
7. Pharmacists Central to Distributing Pediatric COVID-19 Vaccines
As trusted source of information for parents, pharmacists are a key part of the plan to distribute the COVID-19 vaccine to newly eligible children.
6. Five New Year’s Resolutions for Independent Pharmacy Owners
Let’s raise a glass to all the pharmacy owners who are improving patient health outcomes by providing innovative services.
5.Thank You, Pharmacists: National Pharmacist Day 2022
National Pharmacist Day is today, January 12! Today we would like to thank and honor all pharmacists across the country.
4. This Week in COVID-19: A Patent-Free COVID-19 Vaccine May Be On The Horizon
COVID-19 updates and news to know as of January 17, 2022.
3. Group Calls for New Model of Care for Migraine
Current migraine care recommendations do not reflect recent advances in the scientific understanding of migraine disease.
2. 2021 Pharmacy Award Winners, the Best of the Best
Four winners of the SingleCare Best of the Best Pharmacy Awards joined Drug Topics® to share their knowledge with fellow pharmacists and pharmacy technicians.
1. Supreme Court Ruling Blocks COVID-19 Vaccine Mandate for Employers
The employee mandate would have impacted 84 million workers.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.